Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Safety & Tolerability
Who Should Avoid Using PT-141
By activating all three receptors, retatrutide is designed to suppress appetite, and preclinical and early-phase data suggest it may also increase energy expenditure and improve metabolic function though robust long-term human evidence for the energy expenditure effect remains limited
[14] [15] Symptoms may include pain in the upper right abdomen, fever, or yellowing of the skin or eyes (jaundice)
Metformin acts primarily to suppress glucose production in the liver
Product and Regulatory Compliance Tracking aligned with pharmaceutical regulations and clinical trial approval standards for diabetes and obesity treatments
